Results 31 to 40 of about 234,176 (365)

The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortality

Haematologica, 2011
Background The 2005 National Institutes of Health Consensus Development Conference on chronic graft-versus-host disease proposed major changes in the classification and grading of severity of chronic graft-versus-host disease.Design and Methods We aimed ...
Joseph Pidala, Jongphil Kim, Claudio Anasetti, Taiga Nishihori, Brian Betts, Teresa Field, Janelle Perkins   +6 more
doaj   +1 more source

Hemodynamic effects of stent-graft introducer sheath during thoracic endovascular aortic repair [PDF]

Biomechanics and Modeling in Mechanobiology (2022), 2021
Thoracic endovascular aortic repair (TEVAR) has become the standard treatment of a variety of aortic pathologies. The objective of this study is to evaluate the hemodynamic effects of stent-graft introducer sheath during TEVAR. Three idealized representative diseased aortas of aortic aneurysm, coarctation of the aorta, and aortic dissection were ...
arxiv   +1 more source

Graft-versus-host disease [PDF]

Journal of the American Academy of Dermatology, 2012
Approximately 25,000 allogeneic hematopoietic cell transplants are performed worldwide each year for a variety of malignant and non-malignant conditions. Graft-versus-host disease represents one of the most frequent complications and is a major source of long-term morbidity and mortality.
Amin M. Alousi, Edward W. Cowen, Sharon R. Hymes   +2 more
openaire   +8 more sources

Improved survival after acute graft- [PDF]

, 2017
A cute graft- versus -host disease remains a major threat to a successful outcome after allogeneic hematopoietic cell transplantation. While improvements in treatment and supportive care have occurred, it is unknown whether these advances have resulted ...
Aljurf, Mahmoud, Alousi, Amin, Antin, Joseph H., Arora, Mukta, Battiwalla, Minoo, Cahn, Jean-Yves, Cairo, Mitchell, Carabasi, Matthew, Chen, Yi-Bin, Couriel, Daniel, Cutler, Corey, Dandoy, Christopher, Gale, Robert Peter, Gergis, Usama, Hashmi, Shahrukh, Hayashi, Robert J., Hematti, Peiman, Hemmer, Michael T., Jagasia, Madan, Jamani, Kareem, Juckett, Mark, Kamble, Rammurti T., Kharfan-Dabaja, Mohamed, Khoury, Hanna J., Lehmann, Leslie, Litzow, Mark, Majhail, Navneet, Martino, Rodrigo, Miller, Alan, Nishihori, Taiga, Pidala, Joseph, Qayed, Muna, Savani, Bipin, Schoemans, Helene, Schouten, Harry C., Schultz, Kirk R., Socie, Gerard, Solh, Melham, Spellman, Stephen, Storek, Jan, Verdonck, Leo, Vij, Ravi, Wang, Tao, Wirk, Baldeep M., Wood, William A., Yu, Lolie   +45 more
core   +2 more sources

Vitiligo-like manifestations of graft-versus-host disease in a pediatric population [PDF]

, 2022
Vitiligo-like changes are an uncommon cutaneous manifestation of graft-versus-host disease (GVHD). We report three cases and review the literature of pediatric patients with vitiligo-like changes associated with GVHD.
Dai, Julia, Grullon, Karina, Hight, Robert S., Stein, Sarah L., Xiao, Teresa L.   +4 more
core   +1 more source

Stem Cell Transplantation As A Dynamical System: Are Clinical Outcomes Deterministic? [PDF]

Frontiers in Immunology (2014). 5:613, 2014
Outcomes in stem cell transplantation (SCT) are modeled using probability theory. However the clinical course following SCT appears to demonstrate many characteristics of dynamical systems, especially when outcomes are considered in the context of immune reconstitution.
arxiv   +1 more source

Graft versus host disease [PDF]

Journal of the American Academy of Dermatology, 1981
Graft versus host disease (GVHD) occurs in 50% to 70% of patients receiving bone marrow transplants. It can also develop in immunosuppressed patients with malignancies who receive nonirradiated blood transfusions. Most work indicates that the primary mechanism of GVHD is cell-mediated. It is likely that humoral factors are involved as well.
openaire   +5 more sources

Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults

Haematologica, 2016
We previously reported that bone marrow grafts from matched sibling donors resulted in best graft-versus-host disease-free, relapse-free survival at 1-year post allogeneic hematopoietic cell transplantation.
Rohtesh S. Mehta, Regis Peffault de Latour, Todd E DeFor, Marie Robin, Aleksandr Lazaryan, Aliénor Xhaard, Nelli Bejanyan, Flore Sicre de Fontbrune, Mukta Arora, Claudio G. Brunstein, Bruce R. Blazar, Daniel J. Weisdorf, Margaret L. MacMillan, Gerard Socie, Shernan G. Holtan   +14 more
doaj   +1 more source

Predictive models for ocular chronic graft-versus-host disease diagnosis and disease activity in transplant clinical practice

Haematologica, 2015
Ocular chronic graft-versus-host disease is one of the most bothersome common complications following allogeneic hematopoietic stem cell transplantation.
Lauren M. Curtis, Manuel B. Datiles, Seth M. Steinberg, Sandra A. Mitchell, Rachel J. Bishop, Edward W. Cowen, Jacqueline Mays, John M. McCarty, Zoya Kuzmina, Filip Pirsl, Daniel H. Fowler, Ronald E. Gress, Steven Z. Pavletic   +12 more
doaj   +1 more source

Chronic graft-versus-host disease: clinical presentation of multiple lesions of lichenoid and atrophic pattern [PDF]

Anais Brasileiros de Dermatologia, 2013
Graft-versus-host disease is observed mainly in recipients of hematopoietic cell transplantation and is expressed by cutaneous or systemic signals and symptoms. Graft-versus-host disease is clinically classified as acute or chronic.
Luiza Vasconcelos, Erica Cristina Vieira, Eliana Maria Minicucci, Ana Gabriela Salvio, Mair Pedro de Souza, Mariangela Esther Alencar Marques, Silvio Alencar Marques   +6 more
doaj   +1 more source